Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER_GOV × Immunotherapy × Clear all

Phase

Phase 2 2 Phase 1 1

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 5 Uveal Melanoma 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Recurrence 3 Polycystic Ovary Syndrome 3 Neoplasms, Plasma Cell 3 Multiple Myeloma 3 Lymphoma, B-Cell 3 Hematologic Neoplasms 3 Glioblastoma 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Lymphoma, Follicular 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Thymoma 1 Stomatitis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03619954 2018-08-08

NK Cells Infusion for Advanced Malignancies

Anhui Provincial Hospital

Phase 1 Unknown

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡